Conditions: Prostate Cancer
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 6
Healthy volunteers: no

Brief summary:
The purpose of this study is to find out what effects, good and bad, the combination of docetaxel with CG1940/CG8711 (immunotherapy drugs) have on destroying prostate cancer before removal the prostate (prostatectomy).

Detailed description:

Arms:

Interventions: intervention 1: Docetaxel intervention 2: CG1940/CG8711
Intervention descriptions: intervention 1: Docetaxel 75mg/m2 will be given intravenously every 3 weeks for four cycles. intervention 2: Immunotherapy allogeneic GM-CSF secreting cellular vaccine

Protocol document: